CCT8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.518200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.988200E-01
Normal-vs-Stage2
4.529200E-01
Normal-vs-Stage3
5.342000E-01
Normal-vs-Stage4
6.778600E-01
Stage1-vs-Stage2
4.917200E-01
Stage1-vs-Stage3
2.865400E-01
Stage1-vs-Stage4
4.857600E-01
Stage2-vs-Stage3
3.931600E-01
Stage2-vs-Stage4
8.888000E-01
Stage3-vs-Stage4
4.782600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.342200E-01
Normal-vs-AfricanAmerican
6.112400E-01
Normal-vs-Asian
6.620000E-01
Caucasian-vs-AfricanAmerican
8.311400E-01
Caucasian-vs-Asian
4.944400E-01
AfricanAmerican-vs-Asian
5.111400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.685800E-01
Normal-vs-Female
6.218800E-01
Male-vs-Female
8.376600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.492340E-02
Normal-vs-Age(41-60Yrs)
4.702300E-02
Normal-vs-Age(61-80Yrs)
5.899200E-01
Normal-vs-Age(81-100Yrs)
1.620750E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.103600E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.555200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.332790E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.227900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.362000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.446500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.475400E-01
Normal-vs-Daily Drinker
5.415200E-01
Normal-vs-Weekly Drinker
7.387400E-01
Normal-vs-Occasional Drinker
3.494400E-01
Normal-vs-Social Drinker
7.858200E-01
Non Drinker-vs-Daily Drinker
4.212400E-01
Non Drinker-vs-Weekly Drinker
9.844800E-01
Non Drinker-vs-Occasional Drinker
7.592400E-01
Non Drinker-vs-Social Drinker
9.071200E-01
Daily Drinker-vs-Weekly Drinker
5.133400E-01
Daily Drinker-vs-Occasional Drinker
2.981000E-01
Daily Drinker-vs-Social Drinker
5.356600E-01
Weekly Drinker-vs-Occasional Drinker
7.554000E-01
Weekly Drinker-vs-Social Drinker
9.265400E-01
Occasional Drinker-vs-Social Drinker
6.481600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.237200E-01
Normal-vs-Grade 2
6.575800E-01
Normal-vs-Grade 3
1.038390E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.363800E-01
Grade 1-vs-Grade 3
2.478100E-02
Grade 1-vs-Grade 4
7.237200E-01
Grade 2-vs-Grade 3
6.921900E-02
Grade 2-vs-Grade 4
6.575800E-01
Grade 3-vs-Grade 4
1.038390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.372400E-01
Normal-vs-NonDiabetic
5.435200E-01
Diabetic-vs-NonDiabetic
4.122400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.163200E-01
Normal-vs-NoPancreatitis
8.915000E-01
Pancreatitis-vs-NoPancreatitis
3.925600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.202000E-01
Normal-vs-N1
5.602200E-01
N0-vs-N1
5.431200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.440400E-01
Normal-vs-TP53-NonMutant
9.603000E-01
TP53-Mutant-vs-TP53-NonMutant
2.135200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
